Education
About Us
Working with TipRanks
Follow Us
HST Global (HSTC)
OTHER OTC:HSTC
HSTC Stock Chart & Stats
$0.42
-$0.02(-2.35%)
At close: 4:00 PM EST
$0.42
-$0.02(-2.35%)
Day’s Range― - ―
52-Week Range$0.23 - $1.04
Previous CloseN/A
Volume100.00
Average Volume (3M)0.00
Market Cap
$8.55K
Enterprise ValueN/A
Total Cash (Recent Filing)$10.41K
Total Debt (Recent Filing)$41.60K
Price to Earnings (P/E)―
Beta1.32
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding42,771,380
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-20.06
Price to Book (P/B)-5.38
Price to Sales (P/S)0.00
P/FCF Ratio-152.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
HSTC FAQ
What was HST Global’s price range in the past 12 months?
HST Global lowest stock price was $0.23 and its highest was $1.04 in the past 12 months.
What is HST Global’s market cap?
HST Global’s market cap is $8.55K.
When is HST Global’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were HST Global’s earnings last quarter?
Currently, no data Available
Is HST Global overvalued?
According to Wall Street analysts HST Global’s price is currently Overvalued.
Does HST Global pay dividends?
HST Global does not currently pay dividends.
What is HST Global’s EPS estimate?
HST Global’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HST Global have?
HST Global has 42,771,380 shares outstanding.
What happened to HST Global’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of HST Global?
Currently, no hedge funds are holding shares in HSTC
Company Description
HST Global
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.
Technical Analysis
Scinai Immunotherapeutics
―
GT Biopharma
―
Aditxt
―
Psyence Biomedical
―
Conduit Pharmaceuticals
―